Statement by Mr. François Hollande, President of the Republic, on investment in health for employment and economic development, in New York on September 20, 2016.

France François Hollande · President of France

20 September 2016 · Sustainable Development Goals/UN General Assembly side event on investment in health for employment and economic development · New York, United States

Context
Hollande addressed a high-level meeting in New York on September 20, 2016, presenting a WHO-ILO-OECD report on health investment, employment, and development.
Main themes
Investment in health, job creation, global health workforce shortage, economic development, brain drain, training and education, international cooperation, telemedicine and new technologies, funding mobilization, low-income countries, health security, global epidemics
Duration
~11 min
38th percentile
Words
1,289
38th percentile
Sentences
47
30th percentile
Readability
51
65th percentile
Grade
12.6
52nd percentile
Syntax
3.19
71st percentile
Vocabulary
1.99
9th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 47%47%
  • Economic 23%23%
  • Institutional 13%13%
  • Ceremonial 11%11%
  • Geopolitical 6%6%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

47 sentences in 20 paragraphs

I would like to take this opportunity to salute Mr. Ban Ki-moon for his dedication over the past ten years to the cause that is ours, namely development, peace, and relations between the nations that make up the UN.

I greet the Director-General of the WHO, the Secretary-General of the OECD, the Director-General of the International Labour Organization, and all the personalities present here, and of course, Mrs. Zuma, who has played a significant role in involving Africa in this project.

Together with the President of the Republic of South Africa, Mr. Zuma, we wanted to initiate a reflection on what investment in health could bring, not only to improve well-being and save lives but also to create jobs and be able to define a model of development.

We requested that a report be established and that the effort in health be correlated with the consequences in terms of employment and innovation.

This report has just been communicated to us. It is the result of collaborative work that involved experts from the WHO, the ILO, and the OECD, and allowed all governments to contribute as well. I would like to acknowledge all the heads of government gathered in this room.

This report is very encouraging because it demonstrates that investment in health is undoubtedly the best investment that can be made. This is true for both public actors, governments, and private actors who can associate with it.

This report is not an endpoint; we do not simply need to establish reports. We have the obligation to use this report as a starting point and to take action.

If I were to summarize in broad strokes what the experts have communicated to us, the challenge is the creation of 40 million new jobs that can be generated by 2030, that is to say, in just 15 years in the health sector.

It is also a cry of alarm that is being raised. If nothing is done, if there is no investment in training and support, the risk is that we will be short of 18 million personnel to address health issues, particularly in low-income countries, with the risks that we can already foresee, the major health threats that could strike the world. Because we are all interconnected by health issues. What happens in one country inevitably has consequences for others; we have seen this with Zika or with other epidemics that have at one point caused us concern. When we remember what the Ebola crisis was, of course, it affected several countries in Africa, but transportation, migration, and mobility endangered the entire planet.

I return to the conclusions of the report. There is also a risk, even if we make the investment, even if we train more, even if we meet the needs, which is that where personnel are expected, where they may even be trained, there can be a danger, a threat of brain drain to the detriment of the poorest countries. The risk of shortage is therefore significant, with all the consequences that this can have on health.

I thus arrive at what we need to do. What are the requirements for action? First, we must train and train more, especially in low-income countries. The first investment is training, and the first duty is to train where the needs are greatest.

The second conclusion is that we must have a broad conception of what health personnel are. Of course, this includes doctors, nurses, but it also includes social workers, psychologists, and researchers who can help us advance health in all areas, and access to basic care in all territories.

The third conclusion in terms of action is that we must attract health professionals to the countries and territories that are currently experiencing shortages or are facing a brain drain of their qualified personnel. We might think that this only concerns developing countries or poor or vulnerable countries. No, this truth also applies in developed countries where there are risks of shortages, and we know that in certain areas, not just rural but also in some neighborhoods of our cities, there are not or are no longer the necessary personnel.

The fourth conclusion is that we must use new technologies for training. What are called MOOCs or telemedicine are very important so that we can transmit knowledge, understanding, and research findings everywhere in the world thanks to these new technologies.

We also need, once we have realized what we need to do, to mobilize funding, all funding. Public funding, the role of states, funding from international institutions, and many are concerned here - and private funding, particularly from all health industries that must also realize that the risk of shortage can affect their performance.

And then, there are the funds that we must mobilize, and I remind you, for example, of the Global Fund to Fight AIDS, Tuberculosis, and Malaria. France has always considered it a priority to maintain its contribution at a high level: 360 million euros per year. We are the second-largest contributor, and we do not wish to remain so - if others want to take our place, we would be very happy - but we want this example to be set for others. It is very important that we can have this guarantee that funds will remain at a level commensurate with the risks and threats that have not disappeared.

There is also a will, that of France and also of President Zuma, to lower the price of medicines, particularly innovative medicines, as this can create a considerable inequality in access to health, in developed countries, in emerging countries, and in poor countries. If the price of medicines is inaccessible for certain therapies, then we can think that a part of the population will not be able to exercise their right to be treated equally with other categories of the population worldwide. When in a country - even a poor one - it is known that there is a medicine that can save the life of a child or the life of a person, regardless of their age, and that in this country or in this category of the population, one must give up, that is to say, accept death, because there are no means to access the medicine, it is a risk - I tell you - of revolt, of conflict, and confrontation on a global scale.

I therefore want to emphasize how important it is that we can, with the pharmaceutical industries, limit the inflation of costs and ensure that we control a number of prices.

I want to conclude by saying that the WHO has a crucial role to play. I want to congratulate its Director-General, to express how much her involvement regarding a number of epidemics, her role that has allowed us to produce this report, and to ensure that with President Zuma we can take this initiative to act on the price of medicines. I can never emphasize enough how the World Health Organization is an essential institution for the stability and security of the world, not just for health issues. That is why France is itself a candidate to find a worthy successor to Margaret Chan. I want to say here that it is the respect for this institution that justifies our presence with the pride of being able to present, with President Zuma, a report that will put us before our responsibilities on a global scale.

Yes, investment in health is essential for the world; yes, investment in health creates jobs; yes, it can generate considerable innovations; yes, research is a tremendous asset for hope in the world; that is why I want to say how much this report marks an essential step for the progress of humanity.